Skip to content

Future Proof

Active
Private limited company·Speur- en ontwikkelingswerk op biotechnologisch gebied· 5 yrs active
Duifhuis 6 ·2460 Kasterlee, Belgium
KBO/BCE: BE 0771.480.194
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Future Proof is 2.3% (moderate). The 2024 annual accounts show negative equity (€-19k) and a net result of €-20k. Equity is shrinking by ~75.5% per year across the filed fiscal years. Its solvency ranks better than 9% of 174 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
2.3% Moderate
0%0,5%1,5%4%10%≥25%
Annual accounts: weaker financial profile +Young company +Lower-failure-rate sector

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Signals

1 signal · with evidence
Negative equity
Equity is negative for financial year 2024: liabilities exceed assets. This is the trigger point of the alarm-bell procedure (Belgian CAC).
View the annual accounts

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 19 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 24-07-2025, 7 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 24-07-2025 7 d early 2025-00309021
31-12-2023 31-07-2024 02-02-2024 180 d early 2024-00023165
31-12-2022 31-07-2023 02-10-2023 63 d late 2023-00464611

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-20k
Working capital€-19k

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 24-07-2025 with the NBB · fiscal year 2024 · micro
€-20k€-10k€0€10kOperating result 2022: €-20k€-20kNet result 2022: €-20k€-20kOperating result 2023: €-10k€-10kNet result 2023: €8k€8kOperating result 2024: €-19k€-19kNet result 2024: €-20k€-20k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining Equity: declining trend of ~75.5%/year over 3 fiscal years, indicative, assuming unchanged policy.
€-40k€-30k€-20k€-10k€02025: €-25k (€-26k - €-23k)2026: €-30k (€-32k - €-29k)2027: €-36k (€-38k - €-35k)2022: €-8k2023: €4702024: €-19k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 72 · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency -139.3% 55.0%
better than 9% of 174 sector peers
Net result €-20k €16k
better than 22% of 174 sector peers
Equity €-19k €70k
better than 10% of 174 sector peers
Gross operating margin €116 €41k
better than 31% of 175 sector peers
Staff costs €19k €58k
higher than 35% of 38 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P9
2022: P5 · n=1072023: P15 · n=1552024: P9 · n=1742022 2024
Stable position over 2022-2024 · n=107-174
Net result P22
2022: P20 · n=1072023: P40 · n=1552024: P22 · n=1742022 2024
Stable position over 2022-2024 · n=107-174
Equity P10
2022: P5 · n=1072023: P13 · n=1562024: P10 · n=1742022 2024
Stable position over 2022-2024 · n=107-174
Gross operating margin P31
2022: P19 · n=1082023: P20 · n=1562024: P31 · n=1752022 2024
Stable position over 2022-2024 · n=108-175
Describes the position versus peers, not a forecast.
EBITDA
€-10k
+46.2% 22-24
Net profit
€-20k
- 22-24
Cash flow
€8k
- 22-24
Total assets
€14k
+68.0% 22-24
Equity
€-19k
- 22-24
Working capital
€-19k
- 22-24
Employees (FTE)
1
-10.0% 22-24
Staff costs
€19k
+576.3% 22-24
Show 9 other metrics
Debt
€33k
+326.7% 22-24
Debt ≤ 1y
€33k
+326.7% 22-24
Current ratio
0.42
-60.6% 22-24
Quick ratio
0.42
-24.8% 22-24
Solvency
-139.3%
- 22-24
Debt / equity
-1.72
- 22-24
ROE
102.5%
-94.0% 22-24
ROA
-142.8%
- 22-24
Interest coverage
-45.16
+88.2% 22-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA-
Net profit€-20k
Cash flow-
Staff costs€19k
Income taxes-
Dividends-
Total assets€14k
Equity€-19k
Debt€33k
of which ≤ 1y€33k
of which > 1y-
Working capital€-19k
Employees (FTE)0.9
Ratios (computed)
2024
Current ratio0.42
Quick ratio0.42
Working capital ratio-139.3%
Solvency-139.3%
Debt / equity-1.72
Long-term debt ratio-
Interest coverage-
Gross margin-
Net margin-
ROA-142.8%
ROE102.5%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Full annual accounts (19 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€14k
Current assets 29/58€14k
Stocks & contracts in progress 3€0
Amounts receivable within one year 40/41€13k
Cash & bank 54/58€835
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€14k
Equity 10/15€-19k
Contributions / capital 10/11€12k
Accumulated profits (losses) 14€-31k
Amounts payable 17/49€33k
Amounts payable within one year 42/48€33k
Trade debts payable within one year 44€9k
Income statement
Gross operating margin 9900€116
Operating result 9901€-19k
Financial income 75€6
Financial charges 65€283
Result before taxes 9903€-20k
Net result for the period 9904€-20k
Result to be appropriated 9905€-20k
This table shows the latest fiscal year. 2 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
17 / 100 Critical
050100
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

1 location
Future Proof
Duifhuis 6, 2460 KasterleeSpeur- en ontwikkelingswerk op biotechnologisch gebied
since 20212.319.487.061
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area399 m²
Buildings1
Building footprint90 m²
Volume (LiDAR)63 m³
Tallest building3.2 m

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
13018F0401/00Y000 Flanders 399 m² 1 · 90 m² 3.2 m
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
Address history · 1
12-10-2023
Registered-office move
All acts · 1 updated 2 years ago
2023
12-10-2023 Registered office moved from Lichtaart to Kasterlee Registered-office change
  • Eindeke 15, 2460 Lichtaart → Duifhuis 6, 2460 Kasterlee

Analysis

Financial profile

5 of 5 axes measured
Health17Profitability100Solvency33Growth58Stability94
60 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 17
Profitability 100
Solvency 33
Growth 58
Stability 94

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220
Primary activity highlighted.
Names & trade names
Legal nameNL Future Proof
Registered office
Duifhuis 6
2460 Kasterlee, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.